KPC Pharmaceuticals Inc Total Assets
KPC Pharmaceuticals Inc total assets. Based on the latest financial reports, KPC Pharmaceuticals Inc (600422) holds total assets worth CN¥10.98 Billion CNY (≈ $1.61 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is KPC Pharmaceuticals Inc worth for the company's overall valuation and market capitalisation.
Total Assets of KPC Pharmaceuticals Inc (1997–2025)
Total assets of KPC Pharmaceuticals Inc from 1997 to 2025. This chart illustrates how KPC Pharmaceuticals Inc's total assets have evolved over time, based on quarterly financial data. See latest KPC Pharmaceuticals Inc stock price today for real-time trading data and today's change.
KPC Pharmaceuticals Inc - Asset Composition Analysis
KPC Pharmaceuticals Inc Total Assets Breakdown (December 2025)
KPC Pharmaceuticals Inc total assets breakdown as of December 2025. KPC Pharmaceuticals Inc's total assets of CN¥10.98 Billion consist of 65.6% current assets and 34.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 10.5% |
| Accounts Receivable | CN¥3.81 Billion | 32.4% |
| Inventory | CN¥1.38 Billion | 11.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥630.19 Million | 5.4% |
| Goodwill | CN¥1.50 Billion | 12.7% |
Asset Composition Trend (1997–2025)
This chart illustrates how KPC Pharmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore KPC Pharmaceuticals Inc (600422) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: KPC Pharmaceuticals Inc's current assets represent 65.6% of total assets in 2025, an increase from 61.7% in 1997.
- Cash Position: Cash and equivalents constituted 10.5% of total assets in 2025, up from 8.8% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 2.0% in 1997.
- Asset Diversification: The largest asset category is accounts receivable at 32.4% of total assets.
KPC Pharmaceuticals Inc Competitors by Total Assets
Key competitors of KPC Pharmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Ajanta Pharma Limited
NSE:AJANTPHARM
|
India | Rs56.72 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Porton Fine Chemicals Ltd
SHE:300363
|
China | CN¥8.58 Billion |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA
|
India | Rs135.21 Billion |
KPC Pharmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.95 | 1.78 | 1.84 |
| Quick Ratio | 1.51 | 1.47 | 1.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.37 Billion | CN¥3.77 Billion | CN¥2.58 Billion |
KPC Pharmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between KPC Pharmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.28 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | -6.6% |
| Total Assets | CN¥11.77 Billion |
| Market Capitalization | $981.42 Million USD |
Valuation Analysis
Below Book Valuation: The market values KPC Pharmaceuticals Inc's assets below their book value (0.08x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: KPC Pharmaceuticals Inc's assets decreased by 6.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for KPC Pharmaceuticals Inc (1997–2025)
The table below shows the annual total assets of KPC Pharmaceuticals Inc from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥11.77 Billion ≈ $1.72 Billion |
-6.64% |
| 2024-12-31 | CN¥12.61 Billion ≈ $1.85 Billion |
+2.57% |
| 2023-12-31 | CN¥12.30 Billion ≈ $1.80 Billion |
+30.36% |
| 2022-12-31 | CN¥9.43 Billion ≈ $1.38 Billion |
+6.06% |
| 2021-12-31 | CN¥8.89 Billion ≈ $1.30 Billion |
+9.49% |
| 2020-12-31 | CN¥8.12 Billion ≈ $1.19 Billion |
+9.24% |
| 2019-12-31 | CN¥7.43 Billion ≈ $1.09 Billion |
+7.88% |
| 2018-12-31 | CN¥6.89 Billion ≈ $1.01 Billion |
+8.73% |
| 2017-12-31 | CN¥6.34 Billion ≈ $927.47 Million |
+17.32% |
| 2016-12-31 | CN¥5.40 Billion ≈ $790.52 Million |
+9.17% |
| 2015-12-31 | CN¥4.95 Billion ≈ $724.09 Million |
+63.63% |
| 2014-12-31 | CN¥3.02 Billion ≈ $442.52 Million |
+4.79% |
| 2013-12-31 | CN¥2.89 Billion ≈ $422.29 Million |
+34.11% |
| 2012-12-31 | CN¥2.15 Billion ≈ $314.87 Million |
+32.02% |
| 2011-12-31 | CN¥1.63 Billion ≈ $238.50 Million |
+15.11% |
| 2010-12-31 | CN¥1.42 Billion ≈ $207.20 Million |
+13.81% |
| 2009-12-31 | CN¥1.24 Billion ≈ $182.06 Million |
+7.53% |
| 2008-12-31 | CN¥1.16 Billion ≈ $169.30 Million |
-2.79% |
| 2007-12-31 | CN¥1.19 Billion ≈ $174.16 Million |
+5.48% |
| 2006-12-31 | CN¥1.13 Billion ≈ $165.10 Million |
-8.89% |
| 2005-12-31 | CN¥1.24 Billion ≈ $181.21 Million |
+5.66% |
| 2004-12-31 | CN¥1.17 Billion ≈ $171.49 Million |
+23.79% |
| 2003-12-31 | CN¥946.71 Million ≈ $138.53 Million |
+24.03% |
| 2002-12-31 | CN¥763.28 Million ≈ $111.69 Million |
-0.09% |
| 2001-12-31 | CN¥763.98 Million ≈ $111.79 Million |
-4.36% |
| 2000-12-31 | CN¥798.80 Million ≈ $116.89 Million |
+83.58% |
| 1999-12-31 | CN¥435.12 Million ≈ $63.67 Million |
+7.32% |
| 1998-12-31 | CN¥405.44 Million ≈ $59.33 Million |
+33.26% |
| 1997-12-31 | CN¥304.23 Million ≈ $44.52 Million |
-- |
About KPC Pharmaceuticals Inc
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, comether tablets, specialty herbal products, classic prescription for bones and joint, ant… Read more